Preterm Birth Clinical Trial
— CRAFTOfficial title:
An Investigation Into the Role of Previous in Labour Caesarean Section in Future Preterm Birth Risk and Management Strategies
CRAFT-OBS: Observational Study; To evaluate subsequent pregnancy risk of preterm birth in women with a history of previous caesarean in established labour. This prospective study using clinically acquired cervical length and quantitative fetal fibronectin data will help establish a predictive model of preterm birth <34 weeks and <37 weeks. CRAFT-RCT: Randomised controlled trial arm; To assess treatment for short cervix in women at high risk of preterm birth following a caesarean section at full dilatation CRAFT-IMG: Imaging sub-study; To aid understanding of micro and macrostructural features within the cervix which predisposes to preterm birth in women with a previous full dilatation caesarean section. This will use MRI and an advanced transvaginal ultrasound protocol and to assess if structural changes can be visualised in the cervix.
Status | Recruiting |
Enrollment | 1000 |
Est. completion date | October 1, 2022 |
Est. primary completion date | April 1, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 16 Years and older |
Eligibility | CRAFT-OBS Inclusion Criteria: - Pregnant women under 23+6 weeks gestation with a history of previous caesarean section in labour. - Singleton pregnancy. - Willing and able to give informed consent (with or without interpreter). Exclusion Criteria: - Under 16 years of age. - Inability to give informed consent. - Previous caesarean section carried out before labour. - Women who have been commenced on management with progesterone, a cerclage or arabin pessary as part of their care or another research study CRAFT-RCT: Inclusion criteria: - Pregnant women up to 23+6 weeks gestation with a history of FDCS. - Short cervix (<=25mm) on transvaginal ultrasound scan. Exclusion criteria: - Women with persistent fresh vaginal bleeding evident on speculum examination. - Women with visible fetal membranes evident on speculum examination or open cervix on ultrasound scan. - Women with severe abdominal pain/evidence of sepsis (as judged by attending clinician). - Known significant congenital or structural or chromosomal fetal abnormality. - Suspected or proven rupture of the fetal membranes at the time of recruitment. CRAFT-IMG Inclusion criteria: - Pregnant women between 14+0 and 23+6 weeks gestation with a history of FDCS. Exclusion criteria: - Contraindications to MRI, e.g. claustrophobia, BMI >40 kg/m2 (due to technical limitations of scanner) or a women with a non-MRI compatible metallic implant. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Guy's and St Thomas' Hospital NHS Foundation Trust | London |
Lead Sponsor | Collaborator |
---|---|
Guy's and St Thomas' NHS Foundation Trust | King's College London, University College, London |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | CRAFT-OBS: Number of participants with spontaneous preterm birth rate < 37 weeks gestation | Up to 42 weeks | ||
Primary | CRAFT-RCT: Number of participants with spontaneous preterm birth <34 weeks gestation | Up to 42 weeks | ||
Secondary | CRAFT-OBS: Short-term pregnancy and neonatal outcomes, including a composite of neonatal death and morbidity. | We will assess the number of antepartum/intrapartum stillbirths plus neonatal deaths prior to discharge from neonatal services. | Up to 48 weeks | |
Secondary | CRAFT-OBS: Number of participants with adverse perinatal outcome, defined as a composite outcome of death (antepartum/intrapartum stillbirths plus neonatal deaths prior to discharge from neonatal services) | Up to 48 weeks | ||
Secondary | CRAFT-OBS: Number of participants who deliver <34 weeks gestation | Up to 42 weeks | ||
Secondary | CRAFT-OBS: Gestation at delivery | The proportion of participants who delivery at each gestation of completed weeks | Up to 42 weeks | |
Secondary | CRAFT-OBS: Late miscarriage (14+0-23+6 weeks) rate | Up to 42 weeks | ||
Secondary | CRAFT-OBS: Any cervical length measurements taken antenatally | Up to 42 weeks | ||
Secondary | CRAFT-OBS: Number of antenatal hospital appointments | Up to 42 weeks | ||
Secondary | CRAFT-OBS: Number of hospital admissions | Up to 42 weeks | ||
Secondary | CRAFT-OBS: cervicovaginal fetal fibronectin protein levels taken at any gestation if taken | Up to 42 weeks | ||
Secondary | CRAFT-OBS: Number of ultrasound indicated antenatal interventions | Up to 42 weeks | ||
Secondary | CRAFT-OBS: Predictive modelling (QUIPP app) to evaluate the ability of CL and fFN to determine risk of preterm birth <34 and <37 weeks | Up to 42 weeks | ||
Secondary | CRAFT-OBS: Number of participants with other maternal and fetal morbidities, as per COPOP core outcome set for preterm birth intervention studies | COPOP core outcomes | Up to 48 weeks | |
Secondary | CRAFT-RCT: Number of participants with an adverse perinatal outcome | Up to 48 weeks | ||
Secondary | CRAFT-RCT: Gestation at delivery | Proportion of participants who deliver at each gestation of completed weeks | Up to 42 weeks | |
Secondary | CRAFT-RCT: Number of women needing insertion of a rescue cerclage (done when membranes exposed or bulging) | Up to 30 weeks | ||
Secondary | CRAFT-RCT: Time between intervention and delivery. | Up to 42 weeks | ||
Secondary | CRAFT-RCT - Health costs at 28 days post-delivery. | Up to 48 weeks | ||
Secondary | CRAFT-IMG: Evidence of cervical injury | Size of any cervical lesion and its location seen on MRI or ultrasound scans | Up to 40 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Not yet recruiting |
NCT03418311 -
Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome
|
N/A | |
Not yet recruiting |
NCT03418012 -
Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB
|
N/A | |
Completed |
NCT02993744 -
Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone
|
N/A | |
Active, not recruiting |
NCT02673216 -
Infection and Adverse Pregnancy Outcome
|
||
Completed |
NCT01683565 -
Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood
|
Phase 4 | |
Completed |
NCT01412931 -
Protein and Ultrasound Indicators of Preterm Birth
|
N/A | |
Completed |
NCT01460576 -
Improving Prematurity-Related Respiratory Outcomes at Vanderbilt
|
N/A | |
Completed |
NCT02606058 -
The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures?
|
N/A | |
Terminated |
NCT03715530 -
Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women
|
N/A | |
Completed |
NCT00422526 -
Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial
|
Phase 3 | |
Enrolling by invitation |
NCT04251260 -
Effectiveness of Positioning in Preterm Neonates
|
N/A | |
Completed |
NCT03668860 -
India Dexamethasone and Betamethasone
|
Phase 1 | |
Recruiting |
NCT03638037 -
Correlation Between Maternal Vitamin D Level And Preterm Birth
|
||
Completed |
NCT02225353 -
Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery
|
Phase 2 | |
Recruiting |
NCT03992534 -
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
|
Phase 1 | |
Completed |
NCT03144141 -
Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery
|
N/A | |
Completed |
NCT05210985 -
Examination of the Relationship Between Home Affordances With Development
|
||
Completed |
NCT04021654 -
What is the Future of Vulnerable New-borns
|